NO172285C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-klor-3-sulfamoylbenzosyrehydrazider - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-klor-3-sulfamoylbenzosyrehydrazider

Info

Publication number
NO172285C
NO172285C NO885830A NO885830A NO172285C NO 172285 C NO172285 C NO 172285C NO 885830 A NO885830 A NO 885830A NO 885830 A NO885830 A NO 885830A NO 172285 C NO172285 C NO 172285C
Authority
NO
Norway
Prior art keywords
group
carbon atoms
chloro
preparation
represents hydrogen
Prior art date
Application number
NO885830A
Other languages
English (en)
Norwegian (no)
Other versions
NO172285B (no
NO885830L (no
NO885830D0 (no
Inventor
Endre Palosi
Dezso Korbonits
Erzsebet Molnar
Ida Szvoboda
Laszlo Harsing
Gyoergy Simon
Sandor Virag
Vera Gergely
Katalin Marmorosi
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of NO885830D0 publication Critical patent/NO885830D0/no
Publication of NO885830L publication Critical patent/NO885830L/no
Publication of NO172285B publication Critical patent/NO172285B/no
Publication of NO172285C publication Critical patent/NO172285C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/22Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO885830A 1987-12-30 1988-12-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-klor-3-sulfamoylbenzosyrehydrazider NO172285C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU876131A HU207051B (en) 1987-12-30 1987-12-30 Process for producing 4-chloro-3-sulfamoylbenzoic acid hydrazides and pharmaceutical compositions comprising such compounds

Publications (4)

Publication Number Publication Date
NO885830D0 NO885830D0 (no) 1988-12-30
NO885830L NO885830L (no) 1989-07-03
NO172285B NO172285B (no) 1993-03-22
NO172285C true NO172285C (no) 1993-06-30

Family

ID=10971250

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885830A NO172285C (no) 1987-12-30 1988-12-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-klor-3-sulfamoylbenzosyrehydrazider

Country Status (27)

Country Link
US (1) US4916149A (xx)
EP (1) EP0324988B1 (xx)
JP (1) JPH01213269A (xx)
CN (1) CN1037336A (xx)
AT (1) ATE75467T1 (xx)
AU (1) AU609682B2 (xx)
CA (1) CA1332739C (xx)
CS (1) CS277585B6 (xx)
DD (1) DD283383A5 (xx)
DE (1) DE3870601D1 (xx)
DK (1) DK727488A (xx)
ES (1) ES2034149T3 (xx)
FI (1) FI886045A (xx)
GR (1) GR3004471T3 (xx)
HU (1) HU207051B (xx)
IE (1) IE63246B1 (xx)
IL (1) IL88735A (xx)
NO (1) NO172285C (xx)
NZ (1) NZ227481A (xx)
PH (1) PH25739A (xx)
PL (2) PL157971B1 (xx)
PT (1) PT89368B (xx)
RU (2) RU1838303C (xx)
SU (1) SU1736339A3 (xx)
UA (1) UA19123A (xx)
YU (1) YU47125B (xx)
ZA (1) ZA889729B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017065A2 (en) * 1991-04-01 1992-10-15 Duke University Method of inhibiting fibrosis
FR2708608B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
DE10132896A1 (de) * 2001-07-06 2003-01-16 Bayer Cropscience Ag Heterocyclische Amidderivate
DE102005002130A1 (de) * 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1122541B (de) * 1959-12-28 1962-01-25 Hoechst Ag Verfahren zur Herstellung von Sulfamyl-anthranilsaeuren
DE1158927B (de) * 1961-09-15 1963-12-12 Werner Rahms Grubenstempel
DE2144908C2 (de) * 1971-09-08 1982-12-09 Hoechst Ag, 6000 Frankfurt 5-(3- oder 4-Aminobenzolsulfonylamino)-benzimidazolone-(2) und Verfahren zu ihrer Herstellung
BE793718A (fr) * 1972-01-07 1973-07-05 Merck & Co Inc Aminobenzimidazoles
DE2247828A1 (de) * 1972-09-29 1974-04-04 Hoechst Ag Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung
US4420487A (en) * 1978-04-10 1983-12-13 The Purdue Frederick Company Diuretic and antihypertensive benzimidazoles

Also Published As

Publication number Publication date
PT89368B (pt) 1993-08-31
AU2763188A (en) 1989-07-13
YU47125B (sh) 1994-12-28
EP0324988B1 (de) 1992-04-29
DE3870601D1 (de) 1992-06-04
NO172285B (no) 1993-03-22
CA1332739C (en) 1994-10-25
CS910888A3 (en) 1992-09-16
ATE75467T1 (de) 1992-05-15
PH25739A (en) 1991-10-18
AU609682B2 (en) 1991-05-02
HUT56550A (en) 1991-09-30
NO885830L (no) 1989-07-03
IL88735A0 (en) 1989-07-31
ZA889729B (en) 1989-10-25
RU1838303C (ru) 1993-08-30
HU207051B (en) 1993-03-01
CN1037336A (zh) 1989-11-22
IE883892L (en) 1989-06-30
PT89368A (pt) 1989-12-29
DK727488D0 (da) 1988-12-29
PL157971B1 (pl) 1992-07-31
FI886045A (fi) 1989-07-01
SU1736339A3 (ru) 1992-05-23
NO885830D0 (no) 1988-12-30
ES2034149T3 (es) 1993-04-01
DD283383A5 (de) 1990-10-10
JPH01213269A (ja) 1989-08-28
IL88735A (en) 1992-12-01
EP0324988A1 (de) 1989-07-26
CS277585B6 (en) 1993-03-17
PL158049B1 (pl) 1992-07-31
US4916149A (en) 1990-04-10
YU240188A (en) 1990-10-31
PL276889A1 (en) 1990-04-02
DK727488A (da) 1989-07-01
NZ227481A (en) 1990-11-27
RU1830064C (ru) 1993-07-23
IE63246B1 (en) 1995-04-05
UA19123A (uk) 1997-12-25
GR3004471T3 (xx) 1993-03-31

Similar Documents

Publication Publication Date Title
NO972615D0 (no) Benzimidazolderivater
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
NO161564C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater.
AU7509481A (en) 2-(1,4-benzodioxan-2-ylalicyl)imidazoles
NO172285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-klor-3-sulfamoylbenzosyrehydrazider
ES2038668T3 (es) Vasodilatadores de benzotiazepina dotados de sustitucion aralquilica.
ES477785A1 (es) Procedimiento para la preparacion de nuevas 2-fenilimino- imidazolidinas sustituidas.
PT1051393E (pt) Novos derivados de acidos aminoalcano sulfonico fosfonicos e fosfinicos sua preparacao e sua utilizacao como medicamentos
FI871637A0 (fi) Foerfarande foer framstaellning av 1,5-benzotiazepinderivat.
CS387391A3 (en) Phenylalkylaminoalkyl compounds, process of their preparation andmedicaments comprising said compounds
CA2308315A1 (en) N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
AU586477B2 (en) Hexenoic acids
AU563426B2 (en) 3-alkoxy-2(n-pyrrolidino)-n-pyridyl-n-furyl (or thienyl) methyl propylamines
EP0663384A3 (de) Salze der Pyromellitsäure, ein Verfahren zu ihrer Herstellung sowie deren Verwendung.
AU7384381A (en) Substituted oxadiazoles
IE841441L (en) 1-phenoxy-3-hydroxyindolyl-alkylamino-3-propanols.